At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 70 enrolled
Drug / intervention
PRP +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of Ultrasound Guided Glenohumeral Joint Injections of Platelet Rich Plasma (PRP) Versus Hyaluronic Acid (HA) in the Treatment of Glenohumeral Osteoarthritis: a Randomized, Double-blind Control Trial
In Brief
A Phase 4 clinical trial evaluating PRP, Hyaluronic Acid, and 1 other intervention for Osteoarthritis and Shoulder Pain. Completed, enrolled 70 participants across 1 site.
Detailed Summary
This study seeks to expand the current literature in demonstrating potentially efficacious, conservative treatments in the management of glenohumeral osteoarthritis (OA) and will compare ultrasound-guided injections of hyaluronic acid vs. platelet-rich plasma. We aim to obtain information measuring potential benefits of these interventions and to observe for any adverse events.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Shoulder Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedDec 2016
Primary CompletionNov 2020
TodayJul 2026
First PostedDec 6, 2016
Enrollment StartDec 1, 2014
Primary CompletionNov 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 9.6 years ago
Interventions
PRPbiological
Hyaluronic Aciddrug
Ultrasounddevice